0.8405
price down icon1.23%   -0.0105
after-market Handel nachbörslich: .82 -0.0205 -2.44%
loading

Finanzdaten der Renovorx Inc-Aktie (RNXT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
162.14%
0.27
0.103 0.043 - -
Operating Expenses
8.25%
2.948
3.213 2.675 2.828 3.034
Benefits Costs and Expenses
25.45%
3.165
2.523 - - -
Costs And Expenses
8.25%
2.948
3.213 - - -
Operating Income/Loss
13.89%
-2.678
-3.11 -2.632 -2.828 -3.034
Nonoperating Income/Loss
131.45%
-0.217
0.69 -0.246 0.357 0.645
Income/Loss From Continuing Operations Before Tax
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Net Income/Loss
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.50%
36.58
31.40 0.9455 24.94 24.05
Diluted Average Shares
16.50%
36.58
31.40 0.9455 24.94 24.05
Basic Earnings Per Share
0.00%
-0.08
-0.08 -0.12 -0.10 -0.10
Diluted Earnings Per Share
0.00%
-0.08
-0.08 -0.12 -0.10 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Kapitalisierung:     |  Volumen (24h):